Anand Mahindra on Elon Musk’s Neuralink’s Blindsight device: If this device lives up to…

Elon Musk-owned brain chip startup Neuralink recently got FDA approval for its experimental vision implant - Blindsight. Taking to microblogging site X (formerly Twitter), Musk wrote “The Blindsight device from Neuralink will enable even those who have lost both eyes and their optic nerve to see.” Replying to his post, Mahindra Group Chairman Anand Mahindra said “If this device lives up to these expectations then, much more than Tesla or SpaceX, THIS will be your most enduring gift to humankind.”


Announcing the device, the company said “We have received Breakthrough Device Designation from the FDA for Blindsight. Join us in our quest to bring back sight to those who have lost it. Apply to our Patient Registry and openings on our career page.”
In a separate post, Musk said: “The Blindsight device from Neuralink will enable even those who have lost both eyes and their optic nerve to see. Provided the visual cortex is intact, it will even enable those who have been blind from birth to see for the first time. To set expectations correctly, the vision will at first be low resolution, like Atari graphics, but eventually, it has the potential to be better than natural vision and enable you to see in infrared, ultraviolet or even radar wavelengths, like Geordi La Forge. Much appreciated @US_FDA!”
However, Neuralink has yet to share details about when it expects the Blindsight device to move into human trials.

Commenting on Mahindra’s post, an X user said “This man is on a mission .. inspirational Elon musk”. Another user said “Changing lives in a way that surpasses even the wildest sci-fi dreams!”.
“If it fulfills its promise, this device could revolutionize our future in ways even Tesla and SpaceX have yet to achieve,” commented another.